Melissa A. Forgie

1.4k total citations
16 papers, 994 citations indexed

About

Melissa A. Forgie is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Melissa A. Forgie has authored 16 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Internal Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 4 papers in Hematology. Recurrent topics in Melissa A. Forgie's work include Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Melissa A. Forgie is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Melissa A. Forgie collaborates with scholars based in Canada and Sweden. Melissa A. Forgie's co-authors include Philip S. Wells, Marc Rodger, Michael J. Kovacs, Judy Kovacs, Lisa Duffett, Lana A. Castellucci, Philip S. Wells, Janis Bormanis, Donna Touchie and Geoffrey Lewis and has published in prestigious journals such as JAMA, Blood and Annals of Internal Medicine.

In The Last Decade

Melissa A. Forgie

15 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa A. Forgie Canada	9	720	516	262	161	148	16	994
Juan V. Llau Spain	21	907 1.3×	1.2k 2.3×	645 2.5×	209 1.3×	188 1.3×	83	2.0k
Joseph A. Caprini United States	12	463 0.6×	341 0.7×	198 0.8×	40 0.2×	142 1.0×	21	750
Sara Quenet France	15	624 0.9×	412 0.8×	368 1.4×	113 0.7×	172 1.2×	23	1.0k
L Steidl Italy	14	589 0.8×	465 0.9×	232 0.9×	22 0.1×	178 1.2×	27	890
Sanjeev Chunilal Australia	17	806 1.1×	561 1.1×	213 0.8×	25 0.2×	513 3.5×	60	1.3k
Gerlind Holberg Canada	6	612 0.8×	523 1.0×	296 1.1×	105 0.7×	141 1.0×	9	822
Yen‐Lin Chee Singapore	7	197 0.3×	113 0.2×	263 1.0×	69 0.4×	149 1.0×	22	582
Cynthia Wu Canada	17	834 1.2×	558 1.1×	239 0.9×	18 0.1×	219 1.5×	55	1.1k
Ghazi Alotaibi Saudi Arabia	12	408 0.6×	290 0.6×	136 0.5×	58 0.4×	131 0.9×	30	582
Simon McRae Australia	21	742 1.0×	630 1.2×	385 1.5×	17 0.1×	889 6.0×	60	1.7k

Countries citing papers authored by Melissa A. Forgie

Since Specialization

Citations

This map shows the geographic impact of Melissa A. Forgie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Forgie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Forgie more than expected).

Fields of papers citing papers by Melissa A. Forgie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa A. Forgie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Forgie. The network helps show where Melissa A. Forgie may publish in the future.

Co-authorship network of co-authors of Melissa A. Forgie

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa A. Forgie. A scholar is included among the top collaborators of Melissa A. Forgie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa A. Forgie. Melissa A. Forgie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Wells, Philip S., et al.. (2020). Association of Splanchnic Vein Thrombosis on Survival: 15‐Year Institutional Experience With 1561 Cases. Journal of the American Heart Association. 9(24). e016600–e016600. 7 indexed citations

Duffett, Lisa, Lana A. Castellucci, & Melissa A. Forgie. (2020). Pulmonary embolism: update on management and controversies. BMJ. 370. m2177–m2177. 114 indexed citations

Wells, Philip S., et al.. (2018). Diagnosis of Venous Thromboembolism: 20 Years of Progress. Annals of Internal Medicine. 168(2). 131–140. 35 indexed citations

Wells, Philip S., et al.. (2017). Validation of a Tool for Predicting Bleeding Rates in Patients Treated for Deep Venous Thrombosis and Pulmonary Embolism.

Wells, Philip S., et al.. (2016). PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease. Thrombosis Research. 140. S191–S192. 9 indexed citations

Wells, Philip S., Melissa A. Forgie, & Marc Rodger. (2014). Treatment of Venous Thromboembolism. JAMA. 311(7). 717–717. 152 indexed citations

Lazo‐Langner, Alejandro, Michael J. Kovacs, Philip S. Wells, et al.. (2009). A Systematic Review and Meta-Analysis of Proportions of Thrombosis and Bleeding in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis After Orthopedic Surgery (OS). An Update.. Blood. 114(22). 3125–3125. 1 indexed citations

Lazo‐Langner, Alejandro, Doug Coyle, Philip S. Wells, et al.. (2007). Determining the Optimal Timing of Initiation for Venous Thromboembolism (VTE) Anticoagulant (AC) Prophylaxis (proph) after Orthopedic Surgery (OS).. Blood. 110(11). 305–305. 1 indexed citations

Lazo‐Langner, Alejandro, Doug Coyle, Nicholas Barrowman, et al.. (2006). Clinical Outcomes in Patients Receiving Venous Thromboembolism (VTE) Prophylaxis after Orthopedic Surgery (OS). A Systematic Review and Meta-Analysis of Proportions.. Blood. 108(11). 626–626. 1 indexed citations

10.

Wells, Philip S., David R. Anderson, Marc Rodger, et al.. (2005). A Randomized Trial Comparing 2 Low-Molecular-Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine. 165(7). 733–733. 127 indexed citations

11.

Rodger, Marc, Melissa A. Forgie, Nicole Langlois, et al.. (2003). The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism. Thrombosis and Haemostasis. 90(11). 829–834. 16 indexed citations

12.

Wells, Philip S., et al.. (2003). The Outpatient Bleeding Risk Index. Archives of Internal Medicine. 163(8). 917–917. 100 indexed citations

13.

Forgie, Melissa A.. (2001). Duration of oral anticoagulation in first-episode idiopathic deep vein thrombosis: A Markov decision analysis.. uO Research (University of Ottawa). 1 indexed citations

14.

Forgie, Melissa A.. (1998). Preoperative Autologous Donation Decreases Allogeneic Transfusion but Increases Exposure to All Red Blood Cell Transfusion<subtitle>Results of a Meta-analysis</subtitle>. Archives of Internal Medicine. 158(6). 610–610. 190 indexed citations

15.

Wells, Philip S., et al.. (1998). Expanding Eligibility for Outpatient Treatment of Deep Venous Thrombosis and Pulmonary Embolism With Low-Molecular-Weight Heparin. Archives of Internal Medicine. 158(16). 1809–1809. 233 indexed citations

16.

Wells, Philip S. & Melissa A. Forgie. (1996). Diagnosis of deep vein thrombosis. Biomedicine & Pharmacotherapy. 50(6-7). 235–242. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact